得到了应用

. .

代谢综合征杂志

ISSN: 2167 - 0943

开放访问

伊恩·J·马丁*

伊恩·J·马丁*

伊恩·J·马丁*
主编辑
精神病学和神经遗传学部高级研究员
西澳大利亚大学,澳大利亚

传记

Ian James Martins博士是一个Editor / Reveiwer,用于开放式Acess Pub / MDPI期刊和各种其他国际期刊。光子期刊咨询委员会成员。国际标准和评级(IASR)的国际机构研究员。赋予理查德·库恩研究奖2015年内分泌和新陈代谢。[世界着名的科学家Ian James Martins博士从澳大利亚授予科学博士学位,为营养出色的科学贡献。IAN Martins博士从澳大利亚赋予了医学博士的荣誉学位,在糖尿病中出现了卓越的科学贡献。(荣誉函授)2019年全球Peer Revewer 2019年,全球PEER REVEIW奖,公众,在第22个基本科学指标研究领域排名前1%。国际糖尿病研究杂志(2014-2020)的首席编辑:神经科学(2016-2020),糖尿病杂志和临床研究(2017-2020),案例研究进展(2020-2023),新技术营养和食品科学(2020-2023),全球内分泌和新陈代谢杂志(2020-2023),肥胖和凹凸(2020-2023)的干预(2020-2023)和糖尿病,肥胖和新陈代谢杂志(2020-2022)。位成员(Bit Congray。Inc)具有122的H-Index,Google Scholar Citations(32),研究所统计数据(30),Scopus作者ID:7103152779 / Mendeley Stats(21),UWA研究储存库(18)。科学家咨询董事会(美国)和学术学术与学术界.Edu(公开提到)。过去27年的引文积累了> 11768。Ian James Martins - 语义学者个人资料HTTPS://www.semanticscholar.org/author/ian-james-Martins / 5258067。IAN JAMES MARTINS,H-INDEX 20的语义学者概况,研究分析:IAN J Martins | Ph D | Centre of Excellence for Alzheimer's Disease ...https://www.researchgate.net/profile/Ian_Martins2 under Ian James Martins’ name places publication Research Interest (2008) with an RG score (> 96%) of international SCIENTISTS. ORCID CONNECTING RESEARCHER: Editorial Team www.macrothink.org/journal/index.php/jfs/about/editorialTeamBio/13511 Editorial Team. Ian James Martins. Mail · http://orcid.org/0000-0002-2390-1501. Edith Cowan University, Australia. Frontiers in Genetics places Ian James Martins outputs to be > 99% of all Loop authors. Research Online lists 41 ECU publications that are under Global analysis from Ian James Martins. Prestigious Recognition of Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). Certificates from various international conferences have been received in relation to anti-aging, health and disease. Keynote addresses at, Biomedicine 2018 (Osaka, Japan), Global Experts Meeting on Diabetes, Hypertension, Metabolic Syndrome 2018 (Melbourne, Australia), Immunology World 2018 (Amsterdam, Netherlands), Laboratory Medicine 2018 (Berlin, Germany), Innovate Pharma 2017 (Sydney, Australia), Innovate Neurology 2017(Sydney, Australia) World Diabetes and Endocrinology Summit-2017 (Dubai), Pharmacology and Ethnopharmacology 2016 (Chicago, USA) and AGHC 2016 (1 st Plenary Speaker, Kaohsiung, Taiwan). Chair/Co-chair Sessions on Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine etc, 13th Interantional Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Pipeline 1: Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Programme Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethanopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Research Activity Statistics provided by Publons with comparison to other researchers indicates Ian James Martins to be a VERIFIED REVEIWER. Ian James 2 Martins is now in the 98th percentile as assessed for Publons users by merit. Dr Ian Martins is a reviewer for approx. 50 journals over the past 30 years. Organizing Committee and Advisory Board Member [h-index=69] (approx. 60 conferences): Organizing Committee Member, 3 rd International conference on Neurology and Brain Disorders Milan Italy.during 25- 26,2019, Organizing Committee Member Future Trends in Neurosciences 2019 Brussels, Belgium, Organizing Committee Member, 14th International Conference on Laboratory Medicine & Pathology in London, UK, Organizing Committee Member, 7 th International Conference on Neurology and Neuromuscular Diseases that is slated on October 22-23, 2018 at Madrid, Spain, Organizing Committee Member 3rd Edition of International Conference on Neurology and Brain Disorders (INBC 2019), Organizing Committee Member, Euro Diabetes 2019 Congress, Edinburgh, Scotland Advisory Committee Member, 2nd International Conference on Medicinal Chemistry & Drug Design” (Medicinal Chemistry2019) during August 19-20, 2019 in Barcelona, Spain, Advisory Board Member, Global Experts Meeting on Frontiers in Nanomedicine and Drug Delivery” (Nanodelivery 2019) scheduled during March 18-20, 2019 at London, UK, Organizing Committee Member, Conference on Food Science and Nutrition, 25 -26 February 2019,Rome, Italy, International Conference on PharmScience Research & Development” scheduled in Paris, France during March 04-06, 2019, Advisory Board Member World conference on Microbiology and Immunology2019, May 13-15th , 2019 Cape town, South Africa, Advisory Board Member 5 th Neurological Disorders summit (NDS-2019) in Los Angeles, Organizing Committee Member, International Conference on Traditional Medicine and Ethno botany held at the Valencia, Spain on April 10-12, 2019, Organizing Committee Member, International Conference on Stem Cells, Biobanking and Tissue Preservation scheduled during 12-13th December 2018 at Abu Dhabi, UAE, Organizing Committee Member, International Conference on Heart & Diabetes" (ICHD 2019) along with external scientific association with the researches, academicians, and Pharmaceutical market leaders around the globe, scheduled on August 19- 20, 2019 at Osaka, Japan, Organizing Committee Member, 2 nd International Pharmaceutical Conference and Expo to take place on June 05-07, 2019 in Baltimore, USA, Advisory board member, International Summit on Vaccines and Immunology” (AEM VACCINES-2018) which is scheduled to be held on the 05th - 06th December 2018, etc.

研究兴趣

抗衰老基因,食欲,环境,营养,衰老,新陈代谢

tempobet

TempobetGiriş.

TempobetGiriş.

superbetin

Tipobet YeniGirişAdresi Tipobet e YeniGiriş TipobetGüncelGirişAdresi imajbet girişadresi

MobilbahisGiriş.

arrow_upward.arrow_upward.